IEQ Capital’s Aldeyra Therapeutics ALDX Stock Holding History

IEQ Capital’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Sell	206,593 -59,925	-22%	-$103K	﹤0.01%	1448
2026 Q1	$450K	Buy	266,518 +122,319	+85%	+$536K	﹤0.01%	1355
2025 Q4	$747K	Sell	144,199 -14,954	-9%	-$76.8K	﹤0.01%	1154
2025 Q3	$831K	Buy	159,153 +12,299	+8%	+$64.1K	﹤0.01%	1081
2025 Q2	$562K	Buy	146,854 +102,709	+233%	+$266K	﹤0.01%	1108
2025 Q1	$254K	Buy	+44,145	New	+$261K	﹤0.01%	1258

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

IEQ Capital's ALDX Position: Q2 2026 in Review

IEQ Capital reduced its Aldeyra Therapeutics (ALDX) stake by 22% in Q2 2026, selling an estimated $103K and leaving 206,593 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

IEQ Capital first reported a position in ALDX in Q1 2025 and has held it in 6 quarters since. The position peaked at $831K in Q3 2025. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

IEQ Capital held 206,593 shares of Aldeyra Therapeutics worth $440K as of Q2 2026.
IEQ Capital sold 59,925 Aldeyra Therapeutics shares in Q2 2026, an estimated $103K.
Aldeyra Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1448 holding.
IEQ Capital first reported a position in Aldeyra Therapeutics in Q1 2025 and has held it in 6 quarters since.
IEQ Capital's Aldeyra Therapeutics position peaked at $831K in Q3 2025.
108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.